로딩 중…
지수 로딩 중…
Edgewise Therapeutics, Inc.
EWTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$36.81+5.72%
2026-06-18
Price Chart
Edgewise Therapeutics, Inc.+154.39%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.96B |
| Revenue | $0.00 |
| Net Income | $-176M |
| Total Assets | $519M |
| Net Assets | $493M |
| Value | |
| P/B | 8.03x |
| FCF Yield | -3.75% |
| Profitability | |
| ROE | -35.69% |
| ROA | -33.94% |
| Financial Health | |
| Debt Ratio | 5.13% |
| Total Debt | $4M |
| FCF | $-149M |
| Cash | $33M |
| Current Ratio | 22.61x |
| Performance | |
| 1Y Return | 154.39% |
| 1M Return | 17.12% |
| From 52W High | -9.71% |
| 1Y MDD | -46.20% |
| Trading | |
| Volume | 1,916,932 shares |
| Trading Value | $70M |
| Per Share | |
| EPS | $-1.63 |
| BPS | $5.07 |